GlassScriptPhysician profile
John Bryant Volinsky
NPI 1144251703
$1,184.67
in general payments reported to CMS, 2019-2025
17 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $36.86 · 2021: $164 · 2022: $123 · 2023: $74.20 · 2024: $437 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $497.42 | 2021-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $130.21 | 2019-2025 | Doc Band |
| Glaxosmithkline, LLC. | $75.99 | 2019-2024 | Bexsero |
| Pfizer INC. | $72.36 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $67.18 | 2019-2025 | Enflonsia, Vaxelis, Gardasil 9 |
| Ironshore Pharmaceuticals INC. | $61.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.22 | 2020-2021 | |
| Tris Pharma INC | $35.74 | 2021-2022 | |
| Kaleo, INC. | $32.16 | 2019-2021 | |
| Corium, LLC | $30.13 | 2024-2025 | Azstarys |
| Ars Pharmaceuticals Operations, INC. | $29.82 | 2025 | Neffy |
| Ultragenyx Pharmaceutical INC. | $25.48 | 2022 | |
| Genentech USA, INC. | $22.09 | 2019 | |
| Sobi, INC | $20.16 | 2022 | |
| Verrica Pharmaceuticals INC. | $19.47 | 2024 | Ycanth |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.45 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Volinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.